MARKET

ASMB

ASMB

Assembly Bioscie
NASDAQ
34.00
+1.27
+3.88%
After Hours: 32.51 -1.49 -4.38% 15:36 12/24 EST
OPEN
32.94
PREV CLOSE
32.73
HIGH
34.03
LOW
32.36
VOLUME
72.66K
TURNOVER
--
52 WEEK HIGH
39.71
52 WEEK LOW
7.75
MARKET CAP
537.78M
P/E (TTM)
-7.0639
1D
5D
1M
3M
1Y
5Y
1D
GILD Exercises Option to License Assembly Bio's Herpes Programs
NASDAQ · 1d ago
Analysts Offer Insights on Healthcare Companies: Immunome (IMNM), Assembly Biosciences (ASMB) and Marker Therapeutics (MRKR)
TipRanks · 1d ago
Gilead Sciences Bets On Weekly Pill To Tackle Genital Herpes
Benzinga · 2d ago
BUZZ-Assembly Biosciences rises as Gilead opts to license co's HSV therapies
Reuters · 2d ago
Gilead exercises license for Assembly Biosciences herpes programs
Seeking Alpha · 2d ago
Assembly Biosciences Price Target Maintained With a $50.00/Share by HC Wainwright & Co.
Dow Jones · 2d ago
HC Wainwright & Co. Reiterates Buy on Assembly Biosciences, Maintains $50 Price Target
Benzinga · 2d ago
Gilead Partnership and Positive HSV Data De‑Risk Assembly Biosciences, Supporting Buy Rating and $50 Price Target
TipRanks · 2d ago
More
About ASMB
Assembly Biosciences, Inc. is a biotechnology company, which is engaged in the development of small-molecule therapeutics designed to change the path of serious viral diseases and improve the lives of patients worldwide. Its pipeline includes multiple clinical-stage investigational therapies, including two helicase-primase inhibitors (HPI) targeting recurrent genital herpes; an orally bioavailable hepatitis delta virus (HDV) entry inhibitor, and a potent next-generation capsid assembly modulator (CAM) designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. Its pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) targeting transplant-related herpesviruses, which is undergoing studies to enable a regulatory filing, and it also has additional research programs against multiple antiviral targets. It is advancing two investigational long-acting HPI candidates, ABI-5366 (5366) and (2) ABI-1179 (1179).

Webull offers Assembly Biosciences Inc stock information, including NASDAQ: ASMB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ASMB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ASMB stock methods without spending real money on the virtual paper trading platform.